TipRanks
Go Ultimate55% OFF

David Dai Profile - UBS Analyst

46 Followers

David Dai's Stock Coverage

BNTX
BioNTech SE
Nov 04, 2026BUYReiterated$125.005Ratings0%-5.13%
IOVA
Iovance Biotherapeutics
Nov 03, 2026HOLDAssigned$8.005Ratings0%-84.20%
SNDX
Syndax Pharmaceuticals
Nov 02, 2026HOLDReiterated$33.006Ratings25%+18.70%
KURA
Kura Oncology
Oct 29, 2026BUYReiterated$15.009Ratings50%+3.28%
SMMT
Summit Therapeutics
Oct 26, 2026BUYReiterated$33.0012Ratings25%-12.44%
CATX
Perspective Therapeutics
Oct 23, 2026BUYReiterated$8.005Ratings0%-54.50%
005930
Samsung Electronics
Oct 16, 2026BUYReiterated₩440,0001Ratings0%0.00%
NBTX
Nanobiotix
Sep 25, 2026HOLDReiterated$30.006Ratings――
ENGN
enGene Holdings
Sep 16, 2026HOLDAssigned$2.005Ratings――
CGON
CG Oncology, Inc.
Aug 21, 2026BUYAssigned$90.005Ratings40%+36.04%

Disclaimer: TipRanks collects analysts’ ratings and price targets by scanning publicly available reports on financial websites and by receiving reports from analysts, firms, or customers. The information and statistics displayed might not be accurate, complete, or up-to-date. The analyst ratings provided are the sole responsibility of the source publication. TipRanks holds no liability over the analysts' information, price targets, ratings, or opinions expressed. See how TipRanks ranks experts and calculates performance.

Send Us Reports
If you receive reports that you think we are missing, we will thank you with a free Ultimate upgrade!
Learn More >

David Dai activity FAQ

What is the performance of David Dai's recommendations?
The percentage of profitable recommendations made by David Dai is 50.59%, and the average return per transaction is 6.90%.
What stocks does David Dai cover?
What was David Dai's most profitable rating?
David Dai’s most profitable rating was a buy on CG Oncology, Inc. stock on Aug 18, 2025. The return on the trade was 191.90%.
Where can I see a list of stock analyst ratings?
You can see a list of daily stock analyst ratings here.
What are the most recommended stocks by analysts?
You can see a list of the most recommended stocks by analysts here